Biblio
Export 42 results:
[ Author] Title Type Year Filters: First Letter Of Last Name is I [Clear All Filters]
“In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1037-1052, 2018.
, “Dilated Perivascular Spaces in the Centrum Semiovale Begin to Develop in Middle Age.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1619-1626, 2018.
, “Exercise Prevents Amyloid-β-Induced Hippocampal Network Disruption by Inhibiting GSK3β Activation.”, J Alzheimers Dis, vol. 52, no. 1, pp. 333-43, 2016.
, “Vital Exhaustion and Incidence of Dementia: Results from the Copenhagen City Heart Study.”, J Alzheimers Dis, vol. 67, no. 1, pp. 369-379, 2019.
, “Psychological and Mnemonic Benefits of Nostalgia for People with Dementia.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1327-1344, 2018.
, “Mild Behavioral Impairment and Subjective Cognitive Decline Predict Cognitive and Functional Decline.”, J Alzheimers Dis, vol. 80, no. 1, pp. 459-469, 2021.
, “The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations.”, J Alzheimers Dis, vol. 56, no. 3, pp. 929-938, 2017.
, “Midlife Physical Activity and Cognition Later in Life: A Prospective Twin Study.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1303-1317, 2016.
, “Clinical Effectiveness and Tolerability of Electroconvulsive Therapy in Patients with Neuropsychiatric Symptoms of Dementia.”, J Alzheimers Dis, vol. 57, no. 1, pp. 45-51, 2017.
, “Effects of Composite Supplement Containing Astaxanthin and Sesamin on Cognitive Functions in People with Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1767-1775, 2018.
, “Herpes and Alzheimer's Disease: Subversion in the Central Nervous System and How It Might Be Halted.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1273-1281, 2016.
, “AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1043-1063, 2017.
, “AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders.”, J Alzheimers Dis, vol. 53, no. 2, pp. 583-620, 2016.
, “The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features.”, J Alzheimers Dis, vol. 61, no. 1, pp. 17-28, 2018.
, “Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1235-1247, 2017.
, “Neuroimaging Feature Terminology: A Controlled Terminology for the Annotation of Brain Imaging Features.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1153-1169, 2017.
, “Towards a Pathway Inventory of the Human Brain for Modeling Disease Mechanisms Underlying Neurodegeneration.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1343-60, 2016.
,